| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6897206 Combinations for the treatment of inflammatory disorders |
| 05/24/2005 | US6897203 Polysaccharidic esters of retinoic acid |
| 05/24/2005 | US6897050 Desaturase genes and their use |
| 05/24/2005 | US6896901 Controlling or preventing cognitive dysfunction, hyperglycemia and some infective conditions of the skin in mammals by administering pharmaceutically acceptable effective amount of gugulipid |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 05/19/2005 | US20050107472 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050107418 Macrolides |
| 05/19/2005 | US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 05/19/2005 | US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 05/19/2005 | US20050107406 Angiogenesis inhibitors |
| 05/19/2005 | US20050107403 Carbonylpyridine or carbonylpyrimindine compounds containing another nitrogen containing ring; useful in the treatment of inflammatory, metabolic or malignant conditions |
| 05/19/2005 | US20050107390 i.e. 7-[(3R)-3-Amino-4-(3,4-difluorophenyl)butanoyl]-3-methyl-6-(phenylmethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine, dihydrochloride; antilipemic, antiobesity |
| 05/19/2005 | US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders |
| 05/19/2005 | US20050107375 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050107311 buffalo milk and human milk have comparable GM1 and polysialo-ganglioside levels; infant formula; pet foods; instant milk |
| 05/19/2005 | US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 05/19/2005 | US20050107285 comprising an agent which inhibits Fc gamma RIIIb receptor activity, activation or expression; Rheumatoid Arthritis |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106266 docosahexaenoic acid and a calcium compound (carbonate, hydroxide,sulfate) |
| 05/19/2005 | US20050106235 Nsaid formulation comprising a granular composition and an extra-granular composition |
| 05/19/2005 | US20050106212 Using electrochemical mixture of metal compound and bioactive material; contacting substrate |
| 05/19/2005 | US20050106189 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106136 Controlling capilalries, blood vessels in eye; vision defects |
| 05/19/2005 | US20050106099 Fusion proteins |
| 05/19/2005 | DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes |
| 05/19/2005 | CA2548538A1 Compositions and methods of use for a fibroblast growth factor |
| 05/19/2005 | CA2544853A1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases, and organ transplant rejection |
| 05/18/2005 | EP1530725A1 Materials and methods for inductions of immune tolerance |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1530476A1 Use of reboxetine for the treatment of hot flashes |
| 05/18/2005 | EP1530468A1 Substituted isoxazole derivatives and their use in pharmaceutics |
| 05/18/2005 | EP1530466A2 Use of lck inhibitor for treatment of immunologic diseases |
| 05/18/2005 | EP1430030B1 N-type calcium channel antagonists for the treatment of pain |
| 05/18/2005 | EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1098885B9 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/18/2005 | EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617872A Non crystalline tricyclic triazolobenzazepine derivative |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617855A Inhibitors of cytosolic phospholipase A2 |
| 05/18/2005 | CN1617730A Compositions and methods for enhancing corticosteroid delivery |
| 05/18/2005 | CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators |
| 05/18/2005 | CN1617722A Nicotin-or isonicotin benzothiazole derivatives |
| 05/18/2005 | CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 05/18/2005 | CN1617711A Liposomal delivery of vitamin E based compounds |
| 05/18/2005 | CN1617703A Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof |
| 05/18/2005 | CN1616670A 感染性克隆 Infectious clone |
| 05/18/2005 | CN1616474A Acetamido glucose devicative of indomethacin and its synthetic method and use |
| 05/18/2005 | CN1616459A Adenosine derivatives |
| 05/18/2005 | CN1616452A 维生素d类似物 Vitamin d analogues |
| 05/18/2005 | CN1616404A Anti-oxidizing derivative of aspirin and its synthetic method and use |
| 05/18/2005 | CN1616070A Local external application medicine for treating appendicitis and preparing method |
| 05/18/2005 | CN1616068A Chinese medicine decoction for treating neck-shoulder and waist-leg pain |
| 05/18/2005 | CN1616065A Zhengchaihuyin dripping pill |
| 05/18/2005 | CN1616058A Chinese medicine compound rheumatism preparation for improving bioavailability and medicine effect and preparing method |
| 05/18/2005 | CN1616057A Yujin freeze-dried powder injection and its preparing method |
| 05/18/2005 | CN1616054A Freeze-dried girald daphne powder injection and its preparing method |
| 05/18/2005 | CN1616040A Compound Chinese angelica root freeze-dried powder injectron and its preparing method |
| 05/18/2005 | CN1616019A Yimaikang dispersion tablet and its preparing method |
| 05/18/2005 | CN1615996A Nasal administration preparation containing bupleurum root volatile oil |
| 05/18/2005 | CN1615995A Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method |
| 05/18/2005 | CN1615985A Plaster for treating neck, shoulder and waist and leg pain and its preparing method |
| 05/18/2005 | CN1615980A Active extract of lamtophlomis rotata and its preparing method and use |
| 05/18/2005 | CN1615972A Medicine for treating arthraligia caused by wind, cold and wetness evils and with beauty function and its preparing method |
| 05/18/2005 | CN1615953A Child's chaigui antipyretic effervescent particle and its preparing method |
| 05/18/2005 | CN1615941A Paste external use medicine for treating head ache |
| 05/18/2005 | CN1615929A Medicine for treating wind-dampness syndrome |
| 05/18/2005 | CN1615928A Bupleurum root injection for intravenous injection |
| 05/18/2005 | CN1615893A Prescription of compound skeletal musle relaxant and analgesic containing etezamide and its preparing method |
| 05/18/2005 | CN1615892A Prescription of compound antipyretic analgesic containing etenzamide and its preparing method |
| 05/18/2005 | CN1615888A Medicine composition and its use |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1615834A Non injection medicament containing new sodium houttuyfonate |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1202123C Crystalline forms of IS-[la(pha(2S, 3R),9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl) carbonyl]-amino] actahydro-6H-piridazino [1,2-A] [1,2] diazepin-1-carboxamide |
| 05/18/2005 | CN1202118C Adenosine derivatives |
| 05/18/2005 | CN1202104C 2-phenylpyran-4-one derivatives |
| 05/18/2005 | CN1202095C Heteroaromatic ring compounds |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors |
| 05/18/2005 | CN1202068C Aspirin-triggered lipid mediators |